FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
about
The multiple molecular facets of fragile X-associated tremor/ataxia syndromeRNA-mediated neurodegeneration in fragile X-associated tremor/ataxia syndromeUnstable mutations in the FMR1 gene and the phenotypesRepeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disordersMolecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related DisordersThe fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiologyPrepulse inhibition in patients with fragile X-associated tremor ataxia syndrome.Fragile X-associated tremor/ataxia syndrome: clinical phenotype, diagnosis, and treatmentParkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.Evidence for RNA-mediated toxicity in the fragile X-associated tremor/ataxia syndrome.Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers.Associated features in females with an FMR1 premutationThe cognitive neuropsychological phenotype of carriers of the FMR1 premutation.Emerging topics in FXTAS.Eye movements reveal impaired inhibitory control in adult male fragile X premutation carriers asymptomatic for FXTAS.Fragile x-associated tremor ataxia syndrome: the expanding clinical picture, pathophysiology, epidemiology, and update on treatment.New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype.Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development.Young adult female fragile X premutation carriers show age- and genetically-modulated cognitive impairments.Current research, diagnosis, and treatment of fragile X-associated tremor/ataxia syndrome.Mouse models of the fragile x premutation and the fragile X associated tremor/ataxia syndrome.Abnormal dendrite and spine morphology in primary visual cortex in the CGG knock-in mouse model of the fragile X premutationTemporal dynamics of attentional selection in adult male carriers of the fragile X premutation allele and adult controls.Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.Novel methylation markers of the dysexecutive-psychiatric phenotype in FMR1 premutation women.A cross-sectional analysis of orienting of visuospatial attention in child and adult carriers of the fragile X premutation.Capturing the fragile X premutation phenotypes: a collaborative effort across multiple cohorts.High rates of parkinsonism in adults with autism.Regulatory RNAs in brain function and disorders.Carriers of the fragile X mental retardation 1 (FMR1) premutation allele present with increased levels of cytokine IL-10.X-inactivation in the clinical phenotype of fragile X premutation carrier sisters.Neurological and endocrine phenotypes of fragile X carrier women.CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome.New clinical findings in the fragile X-associated tremor ataxia syndrome (FXTAS)Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.FMR1: a gene with three faces.Ectopic expression of CGG containing mRNA is neurotoxic in mammals.Developmental profiles of infants with an FMR1 premutation.RNA-mediated pathogenesis in fragile X-associated disorders.
P2860
Q26852891-F2C6875A-D427-458C-9705-161A9FF071E7Q26992035-3A55E33B-CDA7-41CF-A373-667C6AC9D633Q26996649-F151336B-6BBD-4A55-9343-654E20C857A2Q27011565-385B33B5-9B00-4E0B-87BF-497FE1FDF775Q28077980-27EB3080-C241-4A70-A585-63DE99F6B630Q30249226-1FFC15B2-1081-4C6A-A428-173ABAA2A4A5Q30454136-994CD2A7-A71B-4854-B9AE-FBEA881344FAQ33477846-4C9E4D64-389E-47BD-A8F8-40ACEC99471FQ33604446-FC1C00FD-B658-4A7C-880E-0DE75CEC14C1Q33649463-BFDF844E-5BA5-46A6-9EF8-25CB485C1C63Q33775794-D5D5E966-E3BA-4D23-945D-B0A33874B738Q33846889-828C1394-3176-494D-AB8A-F3D09BB13BABQ34000722-7FFA3842-81DB-49DE-A388-7A761678107BQ34055459-9194297C-50F6-4558-8341-C9FA4FFE3606Q34077088-E421D0AC-DE35-4DFC-A6BC-CC061ABB154AQ34231104-7A2C2987-9851-4F81-8A7E-6BBA7235FE23Q34329664-4A779CF4-11CE-49B3-A8AB-A635DDBA1538Q34359862-CD716B14-42C3-4E47-8225-C3B284C452C7Q34399389-CC6AFA35-948F-4FD4-A212-3384594FB061Q34630352-BF56DD12-213D-4F6B-84E8-4C47C38190F2Q34983498-A261B4DC-F228-4921-BB59-E51A9DC2447EQ35037764-96FAF1FF-F424-42C2-A543-33D24345BBD4Q35047721-07DFB04C-1E92-48AD-A37E-1DF51B3820BBQ35053183-71FFD4E3-3111-4748-9324-9ED38EA338BDQ35125117-5AEB8D42-5BF0-4821-BF19-9E7F49CFA5A7Q35537475-B03F0047-DDCD-4FE2-9245-E463BEC5BB05Q35559347-01A6F92B-FD81-4B18-B98F-7290508B15C9Q35809701-BB024C82-1DCE-483E-8461-1464346C644FQ36006297-A97A2880-1655-4D4A-9D94-D7FFF4ED6761Q36474429-648DDB08-66B9-4715-9B85-59DF6A26A6AFQ36483349-89D3B4F6-D8C4-4272-AE26-2ACB7150AEDBQ36757091-1CE9C444-A735-428E-B242-B6B9B265ABCAQ36882908-99FB7CAA-5B90-4AB8-9A45-A6CB878C9EDDQ37021134-FF2204E0-D26D-447A-9F66-7F83B01777B8Q37154956-53D4256C-78F4-4E3B-AB53-0B89455E63E8Q37199782-68727C5A-4764-47F8-8864-D38592ABDD59Q37216636-55DE9320-E01F-4B26-8D52-901377655B02Q37223278-ABE42CB6-9684-48F2-878E-3F0581471CE1Q37394408-808A1C16-B815-4B5E-AE32-33FF9FC4FE86Q37399680-A9D35BA1-8961-4A91-B250-EFB16A0886BE
P2860
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@ast
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@en
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@nl
type
label
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@ast
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@en
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@nl
prefLabel
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@ast
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@en
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers.
@nl
P2093
P2860
P1433
P1476
FMR1 CGG repeat length predicts motor dysfunction in premutation carriers
@en
P2093
E Berry-Kravis
J Cogswell
P2860
P304
P356
10.1212/01.WNL.0000281692.98200.F5
P407
P433
P50
P577
2007-12-05T00:00:00Z